Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 142

1.

Intranasal carbetocin reduces hyperphagia in individuals with Prader-Willi syndrome.

Dykens EM, Miller J, Angulo M, Roof E, Reidy M, Hatoum HT, Willey R, Bolton G, Korner P.

JCI Insight. 2018 Jun 21;3(12). pii: 98333. doi: 10.1172/jci.insight.98333. eCollection 2018 Jun 21.

2.

Randomized phase II trial of cixutumumab alone or with cetuximab for refractory recurrent/metastatic head and neck squamous cell carcinoma.

Ferrarotto R, William WN Jr, Tseng JE, Marur S, Shin DM, Murphy B, Cohen EEW, Thomas CY, Willey R, Cosaert J, Harun N, Jack Lee J, Wistuba IW, Haddad RI, Glisson BS.

Oral Oncol. 2018 Jul;82:83-90. doi: 10.1016/j.oraloncology.2018.05.014. Epub 2018 May 19.

PMID:
29909907
3.

An SPR based sensor for allergens detection.

Ashley J, Piekarska M, Segers C, Trinh L, Rodgers T, Willey R, Tothill IE.

Biosens Bioelectron. 2017 Feb 15;88:109-113. doi: 10.1016/j.bios.2016.07.101. Epub 2016 Jul 28.

PMID:
27503408
4.

Optimization of Ta<sub>2</sub>O<sub>5</sub> optical thin film deposited by radio frequency magnetron sputtering.

Shakoury R, Willey RR.

Appl Opt. 2016 Jul 10;55(20):5353-7. doi: 10.1364/AO.55.005353.

PMID:
27409310
5.

Effect of Pore Structure on CO₂ Adsorption Characteristics of Aminopolymer Impregnated MCM-36.

Cogswell CF, Jiang H, Ramberger J, Accetta D, Willey RJ, Choi S.

Langmuir. 2015 Apr 21;31(15):4534-41. doi: 10.1021/la505037f. Epub 2015 Apr 8.

PMID:
25811242
6.

Witness sample preparation for measuring antireflection coatings.

Willey RR.

Appl Opt. 2014 Feb 1;53(4):A52-5. doi: 10.1364/AO.53.000A52.

PMID:
24514249
7.

Simulation comparisons of monitoring strategies in narrow bandpass filters and antireflection coatings.

Willey RR.

Appl Opt. 2014 Feb 1;53(4):A27-34. doi: 10.1364/AO.53.000A27.

PMID:
24514225
8.

An open-label, phase 2 study evaluating the efficacy and safety of the anti-IGF-1R antibody cixutumumab in patients with previously treated advanced or metastatic soft-tissue sarcoma or Ewing family of tumours.

Schöffski P, Adkins D, Blay JY, Gil T, Elias AD, Rutkowski P, Pennock GK, Youssoufian H, Gelderblom H, Willey R, Grebennik DO.

Eur J Cancer. 2013 Oct;49(15):3219-28. doi: 10.1016/j.ejca.2013.06.010. Epub 2013 Jul 5.

PMID:
23835252
9.

Managing heart failure: a critical appraisal of the literature.

Willey RM.

J Cardiovasc Nurs. 2012 Sep-Oct;27(5):403-17. doi: 10.1097/JCN.0b013e31822ad3f3.

PMID:
22067719
10.

Recombination-mediated changes in coreceptor usage confer an augmented pathogenic phenotype in a nonhuman primate model of HIV-1-induced AIDS.

Nishimura Y, Shingai M, Lee WR, Sadjadpour R, Donau OK, Willey R, Brenchley JM, Iyengar R, Buckler-White A, Igarashi T, Martin MA.

J Virol. 2011 Oct;85(20):10617-26. doi: 10.1128/JVI.05010-11. Epub 2011 Aug 3.

11.

Expanded viewpoint for broadband antireflection coating designs.

Willey RR.

Appl Opt. 2011 Mar 20;50(9):C86-9. doi: 10.1364/AO.50.000C86.

PMID:
21460987
12.

Further guidance for broadband antireflection coating design.

Willey RR.

Appl Opt. 2011 Mar 20;50(9):C274-8. doi: 10.1364/AO.50.00C274.

PMID:
21460952
13.

Generation of the pathogenic R5-tropic simian/human immunodeficiency virus SHIVAD8 by serial passaging in rhesus macaques.

Nishimura Y, Shingai M, Willey R, Sadjadpour R, Lee WR, Brown CR, Brenchley JM, Buckler-White A, Petros R, Eckhaus M, Hoffman V, Igarashi T, Martin MA.

J Virol. 2010 May;84(9):4769-81. doi: 10.1128/JVI.02279-09. Epub 2010 Feb 10.

14.

Neutralizing antibody titers conferring protection to macaques from a simian/human immunodeficiency virus challenge using the TZM-bl assay.

Willey R, Nason MC, Nishimura Y, Follmann DA, Martin MA.

AIDS Res Hum Retroviruses. 2010 Jan;26(1):89-98. doi: 10.1089/aid.2009.0144.

15.

Monitoring error compensation in general optical coatings.

Willey RR.

Appl Opt. 2009 Aug 1;48(22):4475-82.

PMID:
19649053
16.

Non-turning-point monitoring improves narrow bandpass filters.

Willey RR.

Appl Opt. 2009 Jun 20;48(18):3277-83.

PMID:
19543332
17.

Building blocks for nonpolarizing optical coatings.

Willey RR.

Appl Opt. 2008 Nov 20;47(33):6230-5.

PMID:
19023388
18.
19.
20.
21.

Design of blocking filters of any narrow bandwidth.

Willey RR.

Appl Opt. 2007 Mar 10;46(8):1201-4.

PMID:
17318239
22.

N-terminal acetylation and protonation of individual hemoglobin subunits: position-dependent effects on tetramer strength and cooperativity.

Ashiuchi M, Yagami T, Willey RJ, Padovan JC, Chait BT, Popowicz A, Manning LR, Manning JM.

Protein Sci. 2005 Jun;14(6):1458-71.

23.
24.

Amino acid deletions are introduced into the V2 region of gp120 during independent pathogenic simian immunodeficiency virus/HIV chimeric virus (SHIV) infections of rhesus monkeys generating variants that are macrophage tropic.

Imamichi H, Igarashi T, Imamichi T, Donau OK, Endo Y, Nishimura Y, Willey RL, Suffredini AF, Lane HC, Martin MA.

Proc Natl Acad Sci U S A. 2002 Oct 15;99(21):13813-8. Epub 2002 Oct 7.

25.

Simulation of errors in the monitoring of narrow bandpass filters.

Willey RR.

Appl Opt. 2002 Jun 1;41(16):3193-5.

PMID:
12064401
26.

Fats, oils, and greases: the minimization and treatment of wastewaters generated from oil refining and margarine production.

Willey R.

Ecotoxicol Environ Saf. 2001 Oct;50(2):127-33. No abstract available.

PMID:
11689028
27.

Chemical treatment of an anionic surfactant wastewater: Electrospray-MS studies of intermediates and effect on aerobic biodegradability.

Mantzavinos D, Burrows DM, Willey R, Lo Biundo G, Zhang SF, Livingston AG, Metcalfe IS.

Water Res. 2001 Oct;35(14):3337-44.

PMID:
11547854
28.

Neutralizing antibody directed against the HIV-1 envelope glycoprotein can completely block HIV-1/SIV chimeric virus infections of macaque monkeys.

Shibata R, Igarashi T, Haigwood N, Buckler-White A, Ogert R, Ross W, Willey R, Cho MW, Martin MA.

Nat Med. 1999 Feb;5(2):204-10.

PMID:
9930869
30.

Murine leukemia virus envelope protein in transgenic-mouse serum blocks infection in vitro.

Nihrane A, Fujita K, Willey R, Lyu MS, Silver J.

J Virol. 1998 Oct;72(10):8462. No abstract available.

31.

Randomised placebo-controlled crossover trial on effect of inactivated influenza vaccine on pulmonary function in asthma.

Nicholson KG, Nguyen-Van-Tam JS, Ahmed AH, Wiselka MJ, Leese J, Ayres J, Campbell JH, Ebden P, Eiser NM, Hutchcroft BJ, Pearson JC, Willey RF, Wolstenholme RJ, Woodhead MA.

Lancet. 1998 Jan 31;351(9099):326-31.

PMID:
9652613
32.

Characterization of Silica-Containing Aluminum Hydroxide and Oxide Aerogels

Trombetta M, Busca G, Willey RJ.

J Colloid Interface Sci. 1997 Jun 15;190(2):416-26.

PMID:
9241185
33.

Estimating the number of layers required and other properties of blocker and dichroic optical thin films.

Willey RR.

Appl Opt. 1996 Sep 1;35(25):4982-6. doi: 10.1364/AO.35.004982.

PMID:
21102924
35.
36.

Low-temperature calorimetric properties of zinc ferrite nanoparticles.

Ho JC, Hamdeh HH, Chen YY, Lin SH, Yao YD, Willey RJ, Oliver SA.

Phys Rev B Condens Matter. 1995 Oct 1;52(14):10122-10126. No abstract available.

PMID:
9980060
37.

Nonperturbative lattice simulation bounds on high multiplicity cross sections in phi42.

Mawhinney RD, Willey RS.

Phys Rev Lett. 1995 May 8;74(19):3728-3731. No abstract available.

PMID:
10058282
38.

Scheme dependence of the electroweak radiative corrections.

Bochkarev AI, Willey RS.

Phys Rev D Part Fields. 1995 Mar 1;51(5):R2049-R2052. No abstract available.

PMID:
10018729
44.

Towards a structure of the HIV-1 envelope glycoprotein gp120: an immunochemical approach.

Moore JP, Jameson BA, Sattentau QJ, Willey R, Sodroski J.

Philos Trans R Soc Lond B Biol Sci. 1993 Oct 29;342(1299):83-8.

PMID:
7904352
45.

Predicting achievable design performance of broadband antireflection coatings.

Willey RR.

Appl Opt. 1993 Oct 1;32(28):5447-51. doi: 10.1364/AO.32.005447.

PMID:
20856354
46.

Ambiguity of calculations in the Nambu-Jona-Lasinio model and its singular relation to the linear sigma model.

Willey RS.

Phys Rev D Part Fields. 1993 Sep 15;48(6):2877-2880. No abstract available.

PMID:
10016535
47.

The organization of zooplankton epibiont communities.

Threlkeld ST, Chiavelli DA, Willey RL.

Trends Ecol Evol. 1993 Sep;8(9):317-21. doi: 10.1016/0169-5347(93)90238-K.

PMID:
21236181
48.

Human immunodeficiency virus type 1 Vpu protein is an oligomeric type I integral membrane protein.

Maldarelli F, Chen MY, Willey RL, Strebel K.

J Virol. 1993 Aug;67(8):5056-61.

49.
50.

Comment on "Asymptotic estimate of the n-loop QCD contribution to the total e+e- annihilation cross section.

Duncan AH, Willey RS, Samuel MA, Li G, Steinfelds E.

Phys Rev Lett. 1993 Jun 28;70(26):4159. No abstract available.

PMID:
10054062

Supplemental Content

Loading ...
Support Center